NEW YORK – A team from Columbia University's Mailman School of Public Health, the National Institutes of Health, and Texas A&M University has identified a gene expression signature that appears to predict immune responses to Ebola virus infection and may inform future efforts to curb severe, hemorrhagic forms of the disease.